Investigational drug · Phase 3
Maltodextrin
Not approved by FDA. In 4 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Muscle Pain, Chronic Inflammation, Mobility.
Phase 3Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
4
0 still active
All registered trials
146
Any phase or sponsor naming "Maltodextrin"
First trial start
2024
Feb 21, 2024
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "Maltodextrin", any sponsor or status.
Conditions studied
As listed on its trial records.
- Muscle Pain
- Chronic Inflammation
- Mobility
- Joint Pain
- Circulatory; Change
- Gastrointestinal Dysfunction
- Post Exercise Inflammation
- Exercise Recovery
- Muscle Fatigue
Approved drugs for the same conditions: Gastroenterology and liver · Pain and anesthesia
Largest trials
Live from ClinicalTrials.gov: studies naming "Maltodextrin" as an intervention, largest first.
- Green Tea and Reduction of Breast Cancer RiskPivotal-lookingCompleted
University of MinnesotaAcademic, hospital or other
NCT00917735 · 1,075 participants · Start Jul 2009 · Primary completion Jun 2014
Drug: Green tea extract supplement · For: Breast Cancer
Sites: Edina, Minnesota; Maple Grove, Minnesota; Minneapolis, Minnesota · 5 sites in all
- Probiotic and Influenza Vaccination to Reducing Influenza-like Illness Incident in ElderlyPivotal-lookingCompleted
Universitas IndonesiaAcademic, hospital or other
NCT03695432 · 910 participants · Start Oct 2014 · Primary completion Apr 2015
Drug: Flubio · For: Influenza-like Illness
Sites: Jakarta, Indonesia
- Emergency Department Probiotic Treatment of Pediatric GastroenteritisPivotal-lookingCompleted
Dr. Stephen FreedmanAcademic, hospital or other
NCT01853124 · 886 participants · Start Nov 2013 · Primary completion May 2017
Drug: Placebo; Lacidofil · For: Gastroenteritis
Sites: Calgary, Canada; Halifax, Canada; London, Canada · 6 sites in all
- Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's DiseasePivotal-lookingRecruiting
ScandiBio Therapeutics ABIndustry
NCT07062198 · 845 participants (planned) · Start Sep 12, 2025 · Primary completion Sep 2026
Drug: Combined metabolic activators · For: Alzheimer Disease
Sites: Alanya, Turkey (Türkiye); Erzurum, Turkey (Türkiye); Istanbul, Turkey (Türkiye) · 8 sites in all
- Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose IntolerancePivotal-lookingCompleted
Ritter Pharmaceuticals, Inc.Industry
NCT03597516 · 557 participants · Start Jun 26, 2018 · Primary completion Jul 2, 2019
Drug: RP-G28; Placebos · For: Lactose Intolerance
Sites: Birmingham, Alabama; Chula Vista, California; Huntington Park, California · 35 sites in all
- Omega-3-Based Nutraceutical Supplementation as Adjunctive Therapy in Adults With Otitis Media With Effusion: A Multicenter, Double-Blind, Randomized Placebo-Controlled TrialPivotal-lookingCompleted
Isola Tiberina - Gemelli Isola Hospital, Rome, ItalyAcademic, hospital or other
NCT07721610 · 501 participants · Start Oct 1, 2025 · Primary completion Apr 1, 2026
Drug: Bilastine 20 mg; Placebo Tablet or Capsule and 2 more · For: Otits Media With Effusion
Sites: Roma, Italy
- Three Measures for the Prevention of Carious Lesions in Preschool ChildrenPivotal-lookingStatus unknown
Zhejiang UniversityAcademic, hospital or other
NCT02341352 · 500 participants (planned) · Start Apr 2013 · Primary completion Apr 2015
Drug: fluoride varnish; Immunoglobulin Yolk · For: Dental Caries
Sites: Hangzhou, China
- Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized TrialPivotal-lookingCompleted
Sahlgrenska University HospitalAcademic, hospital or other
NCT04534075 · 354 participants · Start Sep 2, 2020 · Primary completion Sep 14, 2024
Drug: Capsules containing either dietary fiber or placebo · For: Malignant Neoplasm; Malignant Neoplasm of Rectum; Malignant Neoplasm of Anus and 7 more
Sites: Gothenburg, Sweden
- Combined Metabolic Activator Supplementation in Subjects Diagnosed With GoutPivotal-lookingNot yet recruiting
ScandiBio Therapeutics ABIndustry
NCT07889284 · 336 participants (planned) · Start Oct 2026 · Primary completion Feb 2027
Drug: Combined metabolic activators · For: Gout Disease
Sites: Ankara, Turkey (Türkiye); Antalya, Turkey (Türkiye); Erzurum, Turkey (Türkiye) · 12 sites in all
- The Effect of Clindamycin and a Live Biotherapeutic on the Reproductive Outcomes of IVF Patients With Abnormal Vaginal MicrobiotaPivotal-lookingStatus unknown
Peter HumaidanAcademic, hospital or other
NCT05166746 · 333 participants (planned) · Start Dec 7, 2017 · Primary completion Oct 1, 2023
Drug: Clindamycin · For: Bacterial Vaginoses; Infertility, Female
Sites: Copenhagen, Denmark; Hvidovre, Denmark; Skive, Denmark · 4 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Strategy for enhanced production of A40926B0 in Nonomuraea gerenzanensis using an efficient CRISPR/AsCas12f1 system.
Wang X, Zhai H, Gu D, et al. · Synth Syst Biotechnol 2027
- Cordyceps militaris granules reduce EMT/ECM marker expression and alleviate pulmonary fibrosis.
Ji X, Chen K, Liu S, et al. · J Ethnopharmacol 2027
- Pretreatment, physicochemical analysis and structure-activity relationships of antioxidant activities of nine edible mushroom polysaccharides.
Xu C, Cao M, Ma C, et al. · J Sci Food Agric 2027
- Fabrication of pH-intelligent elephant foot yam starch/poly(vinyl alcohol) films using encapsulated dragon fruit peel extract for shrimp freshness monitoring.
Prakruthi LY, Vidya M, Kavuri N, et al. · J Sci Food Agric 2027
- Effects of six weeks of guanidinoacetic acid supplementation with and without creatine monohydrate on cognitive function and markers of health in healthy adults.
Chun J, Babakhani K, Gonzalez DE, et al. · J Int Soc Sports Nutr 2026
- Effects of a slowly fermentable fiber mixture against the background of a high-protein diet on insulin sensitivity and metabolic health in individuals with overweight: a randomized, placebo-controlled trial.
van Kalkeren CAJ, van Deuren T, Coenjaerds MMJ, et al. · Gut Microbes 2026
Also in development for Muscle Pain
- MaolactinPhase 33 trials
RDC Clinical Pty Ltd · Muscle Pain, Chronic Inflammation, Mobility
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.